246. Losonezy, M.L., Davidson, M., Davis, K.L,: The dopamine hypothesis of

schizophrenia. In: ACNP: A New Generation of Progress, H.Y. Meltzer,
(ed.) (in press),

247. Mohs, R.C. and Davis, K.L. The Experimental Pharmacology of Alzheimer's

Disease and Related Dementias. In: ACNP: A New Generation of Progress,
H.Y. Meltzer, (ed.) (in press).

248. Hollander, E., Kapell, L.A., Mohs, R.C., Davidson, M., Davis, B.M., Horvath,
T.B., Davis, K.L. Oral physostigmine in the treatment of Alzheimer's
disease (in review).

249. Davis, B.M. and Davis, K.L. Letter to Lancet. Effect of propantheline on GH
levels and blood glucose levels. Lancet, 1382, 1986.

250. Cocearo, E.F., Siever, L.J., Kourides, LA., Adan, F,, Campbell, G., Davis, K.L
Central serotonergic stimulation by fenfluramine challenge does not affect
plasma TSH levels in man (in review),

251. Davis, K.L, and Mohs, R.C. Response to commentary on Hollander et al.,
antemortem marker paper. Neurobiology of Aging.

23

 

50287574